Mar­ket­ingRx roundup: Phar­ma rep­u­ta­tion lev­el­ing out, Har­ris finds; Pfiz­er speeds up cli­mate change pledge

The phar­ma in­dus­try is set­tling in­to the mid­dle ground of rep­u­ta­tion opin­ion. That’s ac­cord­ing to The Har­ris Poll’s lat­est da­ta with the in­dus­try now hold­ing steady at a 47% fa­vor­able view by con­sumers in June.

The lat­est mea­sure is a dip from phar­ma’s high point in Feb­ru­ary 2021 at 62%, but still a sig­nif­i­cant im­prove­ment over the pre-pan­dem­ic dol­drums at on­ly 32% of con­sumers with a pos­i­tive sen­ti­ment. The in­dus­try had been drop­ping through the 50% ap­proval num­bers since May 2021, but the new June num­bers are dead even with March.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER